AMSURG to Acquire Sheridan Healthcare
By HospiMedica International staff writers Posted on 08 Jun 2014 |
AMSURG (Nashville, TN, USA), a leader in the development, management, and operation of outpatient surgery centers, has agreed to acquire Sheridan Healthcare (Sunrise, FL, USA), a provider of multispecialty outsourced physician services.
Sheridan Healthcare, a leading national provider of multispecialty outsourced physician services to hospitals, ambulatory surgery centers (ASCs), and other healthcare facilities, is the leading provider of anesthesiology services in the USA and the number two provider of children’s services, with strong operations in radiology and emergency medicine services. The cash and stock transaction, valued at approximately USD 2.35 billion, is expected to create a business model that will better meet critical needs for physicians, health systems, communities, and payers.
Strategic benefits include expansion of AMSURG into a highly complementary adjacency, creating significant business, geographic and payer diversity; broader engagement opportunities with physicians, health systems, and payers; the creation of opportunities for collaboration and vertical integration of anesthesia within the existing ASC portfolio; enhanced competencies to address innovation and change in healthcare; and significant expansion of new development opportunities. The combined company will have a total addressable market of approximately USD 70 billion and will encompass more than 4,600 physician relationships across 38 states.
“This will be a combination unlike any other in the marketplace today. The breadth of our value-added services will position us to compete for new outsourced physician contracts, health system partnerships and payer relationships,” said Christopher Holden, president and CEO of AMSURG. “It will allow us to collaborate with our ASC physician partners to pursue the efficient and natural integration of surgery with anesthesia.”
“As part of AMSURG, Sheridan will have enhanced relevance in its existing markets and expanded opportunities in important new markets in more states,” said John Carlyle, CEO of Sheridan Healthcare. “We will also gain entry into additional health systems where we can add value to our clients' strategic objectives. Together, we will be able to leverage the respective reputations, physician networks and strong relationships of both companies to meet the critical needs for health systems, healthcare providers, payers and communities as a whole.”
Related Links:
AMSURG
Sheridan Healthcare
Sheridan Healthcare, a leading national provider of multispecialty outsourced physician services to hospitals, ambulatory surgery centers (ASCs), and other healthcare facilities, is the leading provider of anesthesiology services in the USA and the number two provider of children’s services, with strong operations in radiology and emergency medicine services. The cash and stock transaction, valued at approximately USD 2.35 billion, is expected to create a business model that will better meet critical needs for physicians, health systems, communities, and payers.
Strategic benefits include expansion of AMSURG into a highly complementary adjacency, creating significant business, geographic and payer diversity; broader engagement opportunities with physicians, health systems, and payers; the creation of opportunities for collaboration and vertical integration of anesthesia within the existing ASC portfolio; enhanced competencies to address innovation and change in healthcare; and significant expansion of new development opportunities. The combined company will have a total addressable market of approximately USD 70 billion and will encompass more than 4,600 physician relationships across 38 states.
“This will be a combination unlike any other in the marketplace today. The breadth of our value-added services will position us to compete for new outsourced physician contracts, health system partnerships and payer relationships,” said Christopher Holden, president and CEO of AMSURG. “It will allow us to collaborate with our ASC physician partners to pursue the efficient and natural integration of surgery with anesthesia.”
“As part of AMSURG, Sheridan will have enhanced relevance in its existing markets and expanded opportunities in important new markets in more states,” said John Carlyle, CEO of Sheridan Healthcare. “We will also gain entry into additional health systems where we can add value to our clients' strategic objectives. Together, we will be able to leverage the respective reputations, physician networks and strong relationships of both companies to meet the critical needs for health systems, healthcare providers, payers and communities as a whole.”
Related Links:
AMSURG
Sheridan Healthcare
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures